BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21828038)

  • 1. Dietary isothiocyanate-induced apoptosis via thiol modification of DNA topoisomerase IIα.
    Lin RK; Zhou N; Lyu YL; Tsai YC; Lu CH; Kerrigan J; Chen YT; Guan Z; Hsieh TS; Liu LF
    J Biol Chem; 2011 Sep; 286(38):33591-600. PubMed ID: 21828038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug target.
    Alchanati I; Teicher C; Cohen G; Shemesh V; Barr HM; Nakache P; Ben-Avraham D; Idelevich A; Angel I; Livnah N; Tuvia S; Reiss Y; Taglicht D; Erez O
    PLoS One; 2009 Dec; 4(12):e8104. PubMed ID: 19956605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echinoside A, a new marine-derived anticancer saponin, targets topoisomerase2alpha by unique interference with its DNA binding and catalytic cycle.
    Li M; Miao ZH; Chen Z; Chen Q; Gui M; Lin LP; Sun P; Yi YH; Ding J
    Ann Oncol; 2010 Mar; 21(3):597-607. PubMed ID: 19773249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis.
    Mi L; Xiao Z; Hood BL; Dakshanamurthy S; Wang X; Govind S; Conrads TP; Veenstra TD; Chung FL
    J Biol Chem; 2008 Aug; 283(32):22136-46. PubMed ID: 18524779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II.
    Auzanneau C; Montaudon D; Jacquet R; Puyo S; Pouységu L; Deffieux D; Elkaoukabi-Chaibi A; De Giorgi F; Ichas F; Quideau S; Pourquier P
    Mol Pharmacol; 2012 Jul; 82(1):134-41. PubMed ID: 22528119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dual topoisomerase inhibitor A35 preferentially and specially targets topoisomerase 2α by enhancing pre-strand and post-strand cleavage and inhibiting DNA religation.
    Zhao W; Jiang G; Bi C; Li Y; Liu J; Ye C; He H; Li L; Song D; Shao R
    Oncotarget; 2015 Nov; 6(35):37871-94. PubMed ID: 26462155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform.
    Toyoda E; Kagaya S; Cowell IG; Kurosawa A; Kamoshita K; Nishikawa K; Iiizumi S; Koyama H; Austin CA; Adachi N
    J Biol Chem; 2008 Aug; 283(35):23711-20. PubMed ID: 18596031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells.
    Rao VA; Klein SR; Agama KK; Toyoda E; Adachi N; Pommier Y; Shacter EB
    Cancer Res; 2009 Feb; 69(3):948-57. PubMed ID: 19176392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIα and drug responsiveness.
    Chen CF; He X; Arslan AD; Mo YY; Reinhold WC; Pommier Y; Beck WT
    Mol Pharmacol; 2011 Apr; 79(4):735-41. PubMed ID: 21252292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of topoisomerase IIA (Top2α) induces telomeric DNA damage and T cell dysfunction during chronic viral infection.
    Dang X; Ogbu SC; Zhao J; Nguyen LNT; Cao D; Nguyen LN; Khanal S; Schank M; Thakuri BKC; Wu XY; Morrison ZD; Zhang J; Li Z; El Gazzar M; Ning S; Wang L; Wang Z; Moorman JP; Yao ZQ
    Cell Death Dis; 2020 Mar; 11(3):196. PubMed ID: 32193368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation.
    Guturi KKN; Bohgaki M; Bohgaki T; Srikumar T; Ng D; Kumareswaran R; El Ghamrasni S; Jeon J; Patel P; Eldin MS; Bristow R; Cheung P; Stewart GS; Raught B; Hakem A; Hakem R
    Nat Commun; 2016 Aug; 7():12638. PubMed ID: 27558965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells.
    Wu SY; Pan SL; Xiao ZY; Hsu JL; Chen MC; Lee KH; Teng CM
    PLoS One; 2014; 9(11):e112220. PubMed ID: 25372714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation.
    Wang H; Mao Y; Chen AY; Zhou N; LaVoie EJ; Liu LF
    Biochemistry; 2001 Mar; 40(11):3316-23. PubMed ID: 11258951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase IIα, rather than IIβ, is a promising target in development of anti-cancer drugs.
    Chen W; Qiu J; Shen YM
    Drug Discov Ther; 2012 Oct; 6(5):230-7. PubMed ID: 23229142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinone-induced enhancement of DNA cleavage by human topoisomerase IIalpha: adduction of cysteine residues 392 and 405.
    Bender RP; Ham AJ; Osheroff N
    Biochemistry; 2007 Mar; 46(10):2856-64. PubMed ID: 17298034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
    Deng S; Yan T; Nikolova T; Fuhrmann D; Nemecek A; Gödtel-Armbrust U; Kaina B; Wojnowski L
    Br J Pharmacol; 2015 May; 172(9):2246-57. PubMed ID: 25521189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome p450 enzymes.
    Conaway CC; Krzeminski J; Amin S; Chung FL
    Chem Res Toxicol; 2001 Sep; 14(9):1170-6. PubMed ID: 11559030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIα, enhances DNA breakage, and induces apoptosis in cancer cells.
    Lin TY; Huang CP; Au LC; Chang YW; Hu CY; Lin SB
    Chem Res Toxicol; 2012 Nov; 25(11):2340-51. PubMed ID: 23088786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased negative supercoiling of mtDNA in TOP1mt knockout mice and presence of topoisomerases IIα and IIβ in vertebrate mitochondria.
    Zhang H; Zhang YW; Yasukawa T; Dalla Rosa I; Khiati S; Pommier Y
    Nucleic Acids Res; 2014 Jun; 42(11):7259-67. PubMed ID: 24803675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells.
    Morgan MA; Onono FO; Spielmann HP; Subramanian T; Scherr M; Venturini L; Dallmann I; Ganser A; Reuter CW
    J Mol Med (Berl); 2012 Feb; 90(2):149-61. PubMed ID: 21915711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.